During the past decade, Cabrini Health conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cabrini Health" #1 sponsor was "Minghui Pharmaceutical Pty Ltd" with 2 trials, followed by "Apollomics (Australia) Pty. Ltd." with 1 trials sponsored, "Australian and New Zealand Intensive Care Research Centre" with 1 trials sponsored, "Hutchison Medipharma Limited" with 1 trials sponsored and "LaNova Australia Pty Limited" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cabrini Health" #1 collaborator was "ANZICS Clinical Trials Group" with 1 trials as a collaborator, "Apollomics Inc. (formerly CBT Pharmaceuticals, Inc.)" with 1 trials as a collaborator, "Intensive Care National Audit & Research Centre" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Medical Research Institute of New Zealand" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Cabrini Health" are "Advanced Solid Tumor" (2 trials), "Advanced or Metastatic Solid Tumors" (1 trials), "Cancer of Unknown Primary Site" (1 trials), "Critically Ill, Mechanically Ventilated" (1 trials) and "Hematologic Malignancies" (1 trials). Many other conditions were trialed in "Cabrini Health" in a lesser frequency.

Most popular intervention types in "Cabrini Health" are "Drug" (6 trials), "Biological" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "APL-501" (1 trials), "An Anti-PD-1 Antibody" (1 trials), "EMB-06" (1 trials), "Early activity and mobilisation" (1 trials) and "HMPL-523" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cabrini Health" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cabrini Health". 2 are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cabrini Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cabrini Health, 6 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Cabrini Health has several departments that took part in Clinical trials: "Cabrini Medical Centre; Oncology" - 5 trials